Company Filing History:
Years Active: 2005
Title: Zeljko Zupanovic: Innovator in Tumor Necrosis Factor Inhibition
Introduction
Zeljko Zupanovic is a notable inventor based in Zagreb, Croatia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit tumor necrosis factor alpha (TNF-α) and interleukin 1 (IL-1). His work is crucial in addressing diseases where these mediators are excessively secreted.
Latest Patents
Zupanovic holds a patent for "Thienodibenzoazulene compounds as tumor necrosis factor inhibitors." This invention relates to dibenzoazulene compounds represented by a specific formula, which are designed to inhibit TNF-α and IL-1 in mammals. The compounds also exhibit analgesic properties, making them useful for pain relief.
Career Highlights
Zupanovic is associated with Pliva Istraživački Institut D.o.o., where he has been involved in innovative research and development. His work has contributed to advancements in pharmaceutical preparations aimed at treating various medical conditions.
Collaborations
Zupanovic has collaborated with notable colleagues, including Mladen Mercep and Milan Mesic. Their combined expertise has furthered research in the field of pharmaceutical sciences.
Conclusion
Zeljko Zupanovic's contributions to the development of TNF inhibitors highlight his role as an important figure in pharmaceutical innovation. His work not only addresses critical health issues but also showcases the potential of new compounds in medical treatments.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.